VIM and sarcoidosis: Initially, the authors demonstrated that patients with sarcoidosis showed significantly (p = 0.0024) higher anti-vimentin IgG levels than controls and a greater prevalence of anti-vimentin IgG positivity (24/48: 50 vs.1/13: 7.6%, respectively; p = 0.0091).